Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
investing
2
×
life sciences
national blog main
national top stories
third rock ventures
venture capital
amgen
antisense oligonucleotide
benzodiazepines
biogen
blackstone group
blackstone life sciences
boston
cancer
cancer drugs
cobimetinib
columbia university
david goldstein
deals
depression
epi4k
epilepsy
essential tremor
ipo
kiran reddy
major depressive disorder
marcio souza
new york blog main
new york top stories
perimenopausal depression
praxis precision medicines
ptc therapeutics
revolution medicines
roche
san francisco
san francisco blog main
What
medicines
2
×
research
2
×
aims
backed
cancer
cause
ceo
despite
drug
drugs
epilepsy
family
genes
genetic
hardest
hit
hottest
hunters
ipo
links
marcio
mutations
neuro
new
praxis
precision
proteins
ras
reels
revolution
souza
stop
targets
turn
Language
unset
Current search:
medicines
×
investing
×
research
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
